Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01096290 · ClinicalTrials.gov registry record · Phase 4
Comparison of Lubiprostone and Placebo for the Relief of Constipation From Constipating Medications
A Phase 4 study, sponsored by University of South Alabama.
- Terminated
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
NCT01096290: Clinical Trial Phase 4 study, sponsored by University of South Alabama.
NCT01096290 is a Phase 4 study that was terminated before completion, run by University of South Alabama. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01096290, a Phase 4 study, was terminated before completion, sponsored by University of South Alabama.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
Study Summary
Constipation from medications is a serious and common condition. Lubiprostone has properties that make it a candidate drug. One hundred volunteers with constipation who are taking medications known to cause constipation will be randomized to take lubiprostone or placebo for 28 days. Therapeutic outcome will be evaluated by investigator and study subject assessment.
Interventions
- DRUG Matched placebo
- DRUG lubiprostone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01096290
The ClinicalTrials.gov registry entry for NCT01096290 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Alabama, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Matched placebo is the first listed.
NCT01096290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01096290 about?
NCT01096290 is a clinical study titled "Comparison of Lubiprostone and Placebo for the Relief of Constipation From Constipating Medications". Constipation from medications is a serious and common condition. Lubiprostone has properties that make it a candidate drug. One hundred volunteers with constipation who are taking medications known to cause constipation will be randomized to take lubiprostone or placebo for 28 days. Therapeutic outc...
What is the current status of trial NCT01096290?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2010-04. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01096290?
The interventions under investigation include: Matched placebo (DRUG), lubiprostone (DRUG).
Who is sponsoring clinical trial NCT01096290?
This trial is sponsored by University of South Alabama, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.